دورية أكاديمية
Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study
| العنوان: | Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study |
|---|---|
| المؤلفون: | Catherine Kiptinness, Paulami Naik, Nicholas Thuo, Rachel C. Malen, Julia C. Dettinger, Jillian Pintye, Maeve Rafferty, Edwin Jomo, Nicky Nyamasyo, Tony Wood, Paul Isabelli, Sarah Morris, David Hattery, Andy Stergachis, Daniel Were, Monisha Sharma, Kenneth Ngure, Melissa Latigo Mugambi, Katrina F. Ortblad |
| المصدر: | Frontiers in Public Health, Vol 11 (2023) |
| بيانات النشر: | Frontiers Media S.A. |
| سنة النشر: | 2023 |
| المجموعة: | Directory of Open Access Journals: DOAJ Articles |
| مصطلحات موضوعية: | PrEP, PEP, HIV prevention, telehealth, differentiated service delivery, implementation science, Public aspects of medicine, RA1-1270 |
| الوصف: | BackgroundOnline pharmacies in Kenya provide sexual and reproductive health products (e.g., HIV self-testing, contraception) and could be leveraged to increase the reach of HIV pre-exposure and post-exposure prophylaxis (PrEP/PEP) to populations who do not frequently attend health facilities. To date, evidence is limited for operationalizing online PrEP/PEP delivery and the type of populations reached with this differential service delivery model.MethodsThe ePrEP Kenya Pilot will deliver daily oral PrEP and PEP via MYDAWA, a private online pharmacy retailer, to clients in Nairobi for 18 months. Potential clients will obtain information about PrEP/PEP on MYDAWA's sexual wellness page and self-screen for HIV risk. Individuals ≥18 years, identified as at HIV risk, and willing to pay for a blood-based HIV self-test and PrEP/PEP delivery will be eligible for enrollment. To continue with online PrEP/PEP initiation, eligible clients will purchase a blood-based HIV self-test for 250 KES (~USD 2) [delivered to their setting of choice for 99 KES (~USD 1)], upload an image of their self-test result, and attend a telemedicine visit with a MYDAWA provider. During the telemedicine visit, providers will screen clients for PrEP/PEP eligibility, including clinical concerns (e.g., kidney disease), discuss self-test results, and complete counseling on PrEP/PEP use and safety. Providers will refer clients who self-test HIV positive or report any existing medical conditions to the appropriate services at healthcare facilities that meet their preferences. Eligible clients will be prescribed PrEP (30-day PrEP supply at initiation; 90-day PrEP supply at follow-up visits) or PEP (28-day supply) for free and have it delivered for 99 KES (~USD 1). We will measure PrEP and PEP initiation among eligible clients, PEP-to-PrEP transition, PrEP continuation, and implementation outcomes (e.g., feasibility, acceptability, and costs).DiscussionEstablishing pathways to increase PrEP and PEP access is crucial to help curb new HIV infections in ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 2296-2565 |
| العلاقة: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1054559/fullTest; https://doaj.org/toc/2296-2565Test; https://doaj.org/article/d2fe1bd15b75416a8c86b944a6f2d335Test |
| DOI: | 10.3389/fpubh.2023.1054559 |
| الإتاحة: | https://doi.org/10.3389/fpubh.2023.1054559Test https://doaj.org/article/d2fe1bd15b75416a8c86b944a6f2d335Test |
| رقم الانضمام: | edsbas.B28B1FF2 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 22962565 |
|---|---|
| DOI: | 10.3389/fpubh.2023.1054559 |